The Traderszone Network

25 July, 2017 by The TZ Newswire Staff Comments Off on There Is Only One Empire: Finance

There Is Only One Empire: Finance

By Charles Hugh Smith – Any nation-state that meets these four requirements is fully exposed to a global loss of faith in its economy, debt, a balance of payments and currency. There’s an entire sub-industry in journalism devoted to the idea…

read more

25 July, 2017 by The TZ Newswire Staff Comments Off on Metals Stocks: Gold suffers a second session of losses as investors await Fed update

Metals Stocks: Gold suffers a second session of losses as investors await Fed update

Gold on Tuesday logs its first back-to-back decline in three weeks, while copper notched its highest finish in more than two years.
read more

25 July, 2017 by The TZ Newswire Staff Comments Off on In One Chart: The highest paid athletes in the world, in one chart

In One Chart: The highest paid athletes in the world, in one chart

This graphic shows who makes the most money from a combination of salary, winnings and endorsements.
read more

25 July, 2017 by The TZ Newswire Staff Comments Off on It was a record-setting week for people trying to take guns on planes

It was a record-setting week for people trying to take guns on planes

Most of the guns were loaded, the Brady Campaign said
read more

25 July, 2017 by The TZ Newswire Staff Comments Off on Stock Market Held Support on Monday

Stock Market Held Support on Monday

Welcome to TradingGods.net – Be A Trading God

The stock market indices started the day off with a little pop to resistance, they pulled back and held support the same as they have for the last three consecutive sessions.

The post Stock Market Held Support on Monday appeared first on TradingGods.net.

25 July, 2017 by The TZ Newswire Staff Comments Off on McDonalds Stock at All-Time Highs After Earnings

McDonalds Stock at All-Time Highs After Earnings

McDonald’s hit an all-time high after another solid quarter, solidifying its position as a Dow and broad market leader.

25 July, 2017 by The TZ Newswire Staff Comments Off on An Exciting New Drug Is in Clinical Trials for Aspreva Pharmaceuticals

An Exciting New Drug Is in Clinical Trials for Aspreva Pharmaceuticals

Richard Glickman was the CEO of Aspreva Pharmaceuticals, which put out CellCept, a drug that treats patient with lupus who develop kidney disease. Glickman has moved on to Aurinia Pharmaceuticals (NASDAQ: AUPH), and now is working on another drug, Voclosporin, for the same indication.

read more